Evidence map›Paper›PMID 29693701›Full record

ArticleMolecular medicine reports2018

Cell‑specific and roasting‑dependent regulation of the Keap1/Nrf2 pathway by coffee extracts.

Alexandros Priftis, Antonia-Eugenia Angeli-Terzidou, Aristidis S Veskoukis, Demetrios A Spandidos, Dimitrios Kouretas

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Potential Applications of NRF2 Modulators in Cancer Therapy.Antioxidants (Basel, Switzerland) · 2020
    Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Alexandros PriftisDepartment of Biochemistry and Biotechnology, University of Thessaly, 41500 Larissa, Greece.
Antonia-Eugenia Angeli-TerzidouDepartment of Biochemistry and Biotechnology, University of Thessaly, 41500 Larissa, Greece.
Aristidis S VeskoukisDepartment of Biochemistry and Biotechnology, University of Thessaly, 41500 Larissa, Greece.
Demetrios A SpandidosLaboratory of Clinical Virology, University of Crete, Medical School, 71409 Heraklion, Crete, Greece.
Dimitrios KouretasDepartment of Biochemistry and Biotechnology, University of Thessaly, 41500 Larissa, Greece.
University of Thessaly · GRUniversity of Crete · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coffee is a popular beverage that contains various bioactive compounds. However, its molecular mechanism of action is not fully elucidated. In this context, two previously characterized coffee extracts, a lightly roasted and the corresponding green one, were investigated for their effect on nuclear factor erythroid 2‑related factor 2 (Nrf2) target gene expression in myoblasts and endothelial cells using quantitative PCR. The tested concentrations were non‑cytotoxic and led to improved redox cell status, as was evident by increased reduced glutathione (GSH) levels. In both cell lines, the roasted extract upregulated gene expression more readily than its green counterpart leading to increased NAD(P)H quinone dehydrogenase 1 and γ‑glutamyl cysteine ligase catalytic subunit, among others. The green extract had a mixed effect on the endothelial cells, while, as regards the myoblasts it caused the downregulation of some Nrf‑target genes. Therefore, a potential dose‑ and roasting‑dependent mechanism is proposed in the current study, accounting for coffee's antioxidant activity.

Indexed as

Cell LineCoffeeHumansKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Plant ExtractsSignal TransductionCoffeeKEAP1 protein, humanKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Plant Extracts

Identifiers

PMID29693701
PMCPMC5984008
OpenAlexW2801744738

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.